Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Stanley Druckenmiller’s Top 5 Picks Include Biogen Idec Inc (BIIB), Target Corporation (TGT), Home Depot Inc (HD)

Billionaire Stanley Druckenmiller’s Duquesne Capital revealed its top 5 picks going into 2015 last week. According to the 13F Form filed with the U.S. Securities and Exchange Commission, the largest positions in the hedge fund’s equity portfolio at the end of 2014 consisted of Biogen Idec Inc (NASDAQ:BIIB), Illumina, Inc. (NASDAQ:ILMN), Target Corporation (NYSE:TGT), Home Depot Inc (NYSE:HD), and HDFC Bank Limited (ADR) (NYSE:HDB), the majority of which Druckenmiller was extremely bullish on during the last quarter.

Although Stanley Druckenmiller’s Duquesne Capital closed its doors to investors in 2010 and became a family office, the investment manager continues to issue 13F reports on a quarterly basis. After almost 30 years of providing his clients with high returns, Mr. Druckenmiller retired from the hedge fund business; yet the billionaire has not lost interest in putting his vast wealth to some use. According to Forbes, the investment manager’s net worth is estimated to be $2.8 billion, while his family office’s equity portfolio was valued at $1.02 billion at the end of 2014. Druckenmiller’s trading style is similar to that of George Soros, who favors top-down investments and a long/short hedging technique. Both managers made a name for themselves in 1992, when the duo gained over $1 billion in profits by shorting the British Pound.

With a stake of 359,400 shares, Biogen Idec Inc (NASDAQ:BIIB) was Mr. Druckenmiller’s top pick at the end of the fourth quarter, accounting for almost 12% of the fund’s equity portfolio. During the past quarter, Duquesne Capital increased its exposure to the company by 255,600 shares, a 246% increase in his position, after the stock had gained 19% in the first nine months of 2014. The investment is already paying off, as share prices have already grown by 15% year-to-date. Another important hedge fund betting on Biogen Idec Inc (NASDAQ:BIIB) is Donald Chiboucis‘ Columbus Circle Investors, with a stake of 1.21 million shares.

Illumina, Inc. (NASDAQ:ILMN) continues to rank as Duquesne Capital’s second largest holding, accounting for 7.4% of its equity portfolio with 410,100 shares. The investment firm entered a new position in the company during the third quarter of 2013, and the following year, the stock gained 22.4%. Furthermore, the cap life science tools manufacturer’s earnings per share have experienced a positive and upwards trend over the past two years, repeatedly beating the estimate consensus set forth by analysts. In addition to Duquesne Capital, Illumina, Inc. (NASDAQ:ILMN) is backed by Andreas Halvorsen’s Viking Global, which owns 8.19 million shares and remains bullish, despite the latest reduction to its stake in the company.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.